UNSPSC 51287007: Glucosulfone sodium

This classification denotes a sulfone anti-infective agent with the molecular formula C24H34N2O18S3.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I6RLN7D44F, chemically known as sodium glucosulfone, injection but more generally known as glucosulfone, which bears US NIH Compound Identifier 3481. European Medicines Agency schedules Glucosulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07939MIG. The term GLUCOSULFONE is an International Non-Proprietary Name.

UNSPSC 51287007 Glucosulfone sodium is a Commodity code that nominally classifies a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged under it show minimal relevant procurement activity. The Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium, awarded to Chartwell Rx LLC for $2,999,999.11 over three years, supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride—neither glucosulfone sodium. Seminole County, Florida's June 2026 IFB for Naloxone and Safe Drug Deactivation Systems procurement similarly bears no connection to the code's chemical specificity. The source shows no open solicitations actively seeking glucosulfone sodium itself or demonstrating state and local demand for this ingredient under this code.

The mismatch between the code's narrow pharmaceutical-ingredient scope and the actual work being posted suggests this Commodity code sees little to no state and local procurement activity aligned with its definition. Business development professionals should verify whether their glucosulfone sodium product or service aligns with an alternate, higher-order Family or Class code that captures broader pharmaceutical procurement flows, or whether state and local demand for this specific ingredient is too limited to support an active pursuit strategy under this classification.